Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
about
Caffeic Acid Attenuates Diabetic Kidney Disease via Modulation of Autophagy in a High-Fat Diet/Streptozotocin- Induced Diabetic Rat.Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications.Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients.MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target.Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses.MicroRNAs associated with the development of kidney diseases in humans and animals.Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy.Urinary Extracellular Vesicle: A Potential Source of Early Diagnostic and Therapeutic Biomarker in Diabetic Kidney Disease.MicroRNA and Microvascular Complications of Diabetes.Crosstalk Between the Unfolded Protein Response, MicroRNAs, and Insulin Signaling Pathways: In Search of Biomarkers for the Diagnosis and Treatment of Type 2 Diabetes.
P2860
Q33720118-C17F5EF3-40A0-446C-AF85-5D88CBBD5FEBQ39141563-99B913A2-48AA-42F8-9257-A404E785B19CQ41660553-7FB412C1-0D46-4AC9-BE93-D300D45B63CDQ42361138-4AD7416A-3604-4E26-8CD2-4B1C5B7141BBQ46308323-7ACEA32B-0C84-47ED-A7E7-DFEFD39413C3Q47102988-3204C3EB-ED54-4C1C-98AB-9C191DACC9BFQ47106144-B13EFBC2-EF0A-40FD-8C46-1B4F85F9D1C9Q47561986-17779F21-74A9-4265-90CB-1CFCA345B3EEQ47654194-2CB7F514-0A98-4FC5-842B-54DD7F5247FBQ50068087-694382A6-042A-4FBA-8A3A-B575B9412586Q50352301-5C52FAFB-4891-4688-9A3B-82DB50FBCD69Q55066015-75C3AB25-A77D-4799-81DF-05DEDFDF6548Q55185689-3A99915E-0015-4479-8DC8-FC9B6F8A7B92Q55262853-D14211A3-7744-4ED6-90F1-F1680E42A3EDQ55397060-35598206-1230-4B92-82E6-392069B5F107
P2860
Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical verification of a nov ...... ed by bioinformatics analysis.
@en
type
label
Clinical verification of a nov ...... ed by bioinformatics analysis.
@en
prefLabel
Clinical verification of a nov ...... ed by bioinformatics analysis.
@en
P921
P1476
Clinical verification of a nov ...... ied by bioinformatics analysis
@en
P2093
Miram M Bekhet
P356
10.1016/J.BIOPHA.2016.06.018
P577
2016-06-23T00:00:00Z